Highlights from the 2013 ACCF/AHA guidelines for the management of ST-elevation myocardial infarction and beyond

Clinical Cardiology

Volumn 37, Issue 4, 2014, Pages 252-259

  Tamis Holland, Jacqueline E ^a   O'Gara, Patrick ^b  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT;

ANTICOAGULANT THERAPY; ARTERY DISEASE; BLEEDING TENDENCY; CARDIOGENIC SHOCK; CLINICAL FEATURE; COUNTERPULSATION; FIBRINOLYTIC THERAPY; HEALTH CARE MANAGEMENT; HEART MUSCLE REPERFUSION; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; INTRAAORTIC BALLOON PUMP COUNTERPULSATION; MEDICAL LITERATURE; PATIENT TRANSPORT; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STRATEGIC PLANNING; SUDDEN CARDIAC DEATH; SYMPTOM ASSESSMENT; THROMBUS ASPIRATION; CARDIOLOGY; MEDICAL SOCIETY; MYOCARDIAL INFARCTION; ORGANIZATION AND MANAGEMENT; RISK ASSESSMENT; UNITED STATES;

AMERICAN HEART ASSOCIATION; CARDIOLOGY; HUMANS; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; UNITED STATES;

EID: 84899096522     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22258     Document Type: Review

References (52)

1. Go AS, Mozaffarian D, Roger VL, et al. Heart Disease and Stroke Statistics-2013 Update: a report from the American Heart Association. Circulation. 2013; 127: e6-e245.
2. Yeh R, Sidney S, Chandra M, et al. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010; 362: 2155-2165.
3. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). J Am Coll Cardiol. 2004; 44: e1-e212.
4. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013; 127: e362-e425.
5. Jacobs AK, Antman EM, Faxon DP, et al. Development of systems of care for ST-elevation myocardial infarction patients: executive summary. Circulation. 2007; 116: 217-230.
6. Bradley EH, Curry LA, Webster TR, et al. Achieving rapid door-to-balloon times: how top hospitals improve complex clinical systems. Circulation. 2006; 113: 1079-1085.
7. Bagai A, Jollis JG, Dauerman HL, et al. Emergency department bypass for ST-segment elevation myocardial infarction patients identified with a pre-hospital electrocardiogram: a report From the American Heart Association Mission: Lifeline program. Circulation. 2013; 128: 352-359.
8. Menees DS, Peterson ED, Wang Y, et al. Door-to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med. 2013; 369: 901-909.
9. Concannon TW, Nelson J, Goetz J, et al. A percutaneous coronary intervention lab in every hospital? Cardiovasc Qual Outcomes. 2012; 5: 14-20.
10. Dalby A, Bouzamondo A, Lechat P, et al. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction. A meta-analysis. Circulation. 2003; 108: 1809-1814.
11. Wang TY, Peterson ED, Ou FS, et al. Door-to-balloon times for patients with ST-segment elevation myocardial infarction requiring inter-hospital transfer for primary percutaneous coronary intervention: a report from the National Cardiovascular Data registry. Am Heart J. 2011; 161: 76-83.
12. Rathore SS, Curtis JP, Chen J, et al. Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study. BMJ. 2009; 338: b1807.
13. Pinto D, Frederick PD, Chakrabarti AK, et al. Benefit of transferring ST-Segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase. Circulation. 2011; 124: 2512-2521.
14. Pinto DS, Kirtane AJ, Brahmajee K, et al. Hospital delays in reperfusion for ST-elevation myocardial infarction. Implications when selecting a reperfusion strategy. Circulation. 2006; 114: 2019-2025.
15. Bonnefoy E, Steg PG, Boutitie F, et al. Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5 year follow-up. Eur Heart J. 2009; 30: 1598-1606.
16. Gurwitz JH, Gore JM, Goldberg RJ, et al. Risk for intra-cranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Ann Intern Med. 1998; 129: 597-604.
17. The Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002; 346: 549-556.
18. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002; 346: 557-563.
19. Kim F, Nichol G, Maynard C,. et al. Effect of prehospital induction of mild hypothermia on survival and neurological status among adults with cardiac arrest: a randomized clinical trial. JAMA. 2014; 311: 45-52.
20. Nielsen N, Wetterslev J, Cronberg T, et al. Targeted temperature management at 33 °C versus 36 °C after cardiac arrest. N Engl J Med. 2013; 369: 2197-2206.
21. Dumas F, Cariou A, Manzo-Silberman S, et al. Immediate percutaneous coronary intervention is associated with better survival after out-of-hospital cardiac arrest. Insights from the PROCAT (Parisian Region Out of Hospital Cardiac Arrest) Registry. Circ Cardiovasc Interv. 2010; 3: 200-207.
22. Nichol G, Aufderheide TP, Eigel B, et al. Regional systems of care for out-of-hospital cardiac arrest: a policy statement from the American Heart Association. Circulation. 2010; 121: 709-729.
23. Niccoli G, Burzotta F, Galiuto L, et al. Myocardial no-reflow in humans. J Am Coll Cardiol. 2009; 54: 281-292.
24. Brosh D, Assali AR, Mager A,. Effect of No-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality. Am J Cardiol. 2007; 99: 442-445.
25. Svilaas T, Vlaar PJ, van der Horst IC, et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med. 2008; 358: 557-567.
26. Vlaar PJ, Svilaas T, van der Horst IC, et al. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous Coronary Intervention in Acute Myocardial Infarction Study (TAPAS): a 1-year follow-up study. Lancet. 2008; 371: 1915-1920.
27. Stone GW, Maehara A, Witzenbichler B, et al. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial. JAMA. 2012; 307: 1817-1826.
28. Kumbhani DJ, Bavry AA, Desai MY, et al. Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: an updated meta-analysis of randomized trials. J Am Coll Cardiol. 2013; 62: 1409-1418.
29. Frobert O, Lagerqvist B, Olivecrona GK, et al. Thrombus aspiration during ST-Segment elevation myocardial infarction. N Engl J Med. 2013; 369: 1587-1597.
30. Fernandez-Aviles F, Alonso JJ, Castro-Beiras A, et al. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial. Lancet. 2004; 364: 1045-1053.
31. Di Mario C, Dudek D, Piscione F, et al. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial. Lancet. 2008; 371: 559-568.
32. Cantor WJ, Fitchett D, Borgundvaag B, et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med. 2009; 360: 2705-2718.
33. Bohmer E, Hoffmann P, Abdelnoor M, et al. Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction). J Am Coll Cardiol. 2010; 55: 102-110.
34. Borgia F, Goodman SG, Halvorsen S, et al. Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST- segment elevation myocardial infarction: a meta-analysis. Eur Heart J. 2010; 31: 2156-2169.
35. Armstrong PW, Gershlick AH, Goldstein P, et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med. 2013; 368: 1379-1387.
36. Sinnaeve PR,. One year mortality in STEMI patients randomized to primary PCI or a pharmaco-invasive strategy. The STREAM 1 year follow-up. Paper presented at: American Heart Association Scientific Sessions; November 18, 2013; Dallas, TX.
37. Muller DWM, Topol EJ, Ellis SG, et al. Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction. Am Heart J. 1991; 121: 1042-1049.
38. Di Mario C, Sansa M, Airoldi F, et al. Single vs multivessel treatment during primary angioplasty- results of the multicentre randomized HEpacoat for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study. Int J Cardiovas Interv. 2004; 6: 128-133.
39. Ochala A, Smolka GA, Wojakowski W, et al. The Function of the left ventricle after complete multi-vessel one-stage percutaneous coronary intervention in patients with acute MI. J Invasive Cardiol. 2004; 12: 699-702.
40. Politi L, Sgura F, Rossi R, et al. A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up. Heart. 2010; 96: 662-667.
41. Hannan EL, Samadashvili Z, Walford G, et al. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. JACC Cardiovasc Interv. 2010; 3: 22-31.
42. Vlaar PJ, Mahmoud KD, Holmes DR Jr, et al. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction. A pairwise and network meta-analysis. J Am Coll Cardiol. 2011; 58: 692-703.
43. Wald DS, Morris JK, Wald NJ, et al. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med. 2013; 369: 1115-1123.
44. Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012; 367: 1287-1296.
45. Steinhubl SR, Bhatt DL, Brennan DM, et al. Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding. Ann Intern Med. 2009; 150: 379-386.
46. Mathews R, Peterson ED, Chen AY, et al. ST-Elevation and non-ST-elevation myocardial infarction care: Derivation and validation of a model from the ACTION Registry-GWTG. Am J Cardiol. 2011; 107: 1136-1143.
47. Rao SV, O'Grady K, Pieper KS, et al. A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes. J Am Coll Cardiol. 2006; 47: 809-816.
48. Mehran R, Pocock SJ, Nikolsky E, et al. A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol. 2010; 55: 2556-2566.
49. Giugliano RP, Giraldez RR, Morrow DA, et al. Relations between bleeding and outcomes in patients with ST-elevation myocardial infarction in the ExTRACT-TIMI 25 trial. Eur Heart J. 2010; 17: 2103-2110.
50. Berkowitz S, Granger CB, Pieper KS, et al. Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. Circulation. 1997; 95: 2508-2516.
51. Nikolsky E, Mehran R, Dangas G, et al. Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach. Eur Heart J. 2007; 28: 1936-1945.
52. Romagnoli E, Biondi-Zoccai G, Sciahbasi A, et al. Radial versus femoral randomized investigation in ST-Segment elevation acute coronary syndrome The RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) Study. J Am Coll Cardiol. 2012; 60: 2481-2489.